Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Scientists have developed a framework for stress-testing how AI chatbots respond to vulnerable users, helping researchers identify weaknesses and test ways of making mental-health interactions safer.

A person's hands can be seen typing on a keyboard with an AI chatbot screen superimposed over the top © Shutterstock

Published in Nature Medicine, the study introduces SIM-VAIL, a clinically validated framework for auditing AI chatbots in mental-health conversations. The work was led by researchers at the University of Oxford, University College London (UCL), and the UK AI Security Institute.

SIM-VAIL simulates users with specific psychological vulnerabilities, such as depression, mania, psychosis, obsessive-compulsive disorder, or insecure attachment, and with a wide range of intentions, for example trying to get the chatbot to agree with them, downplay their difficulties or endorse risky actions. It then engages chatbots in multi-turn conversations and scores each exchange across clinically grounded risk dimensions.

The researchers used the framework to investigate 810 conversations with nine frontier AI models (including Claude, ChatGPT, Gemini, Grok and Llama models), spanning 30 simulated user profiles and more than 90,000 clinical ratings.

They found that concerning behaviour in target chatbots was widespread, although this was significantly reduced in newer models. Safety depended strongly on the user’s psychological context and how the conversation developed.

Read the full story on the Department of Psychiatry website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience